CVRx, Inc. (CVRX)
NASDAQ
Market Cap
$371.72M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
211 of 971
Rank in Industry
24 of 120
Largest Insider Buys in Sector
CVRX Stock Price History Chart
CVRX Stock Performance
About CVRx, Inc.
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Insider Activity of CVRx, Inc.
Over the last 12 months, insiders at CVRx, Inc. have bought $322,508 and sold $171,307 worth of CVRx, Inc. stock.
On average, over the past 5 years, insiders at CVRx, Inc. have bought $15.87M and sold $85,840 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hykes Kevin (PRES & CEO) — $250,767. SLATTERY JOSEPH P (director) — $143,482.
The last purchase of 3,000 shares for transaction amount of $24,300 was made by SLATTERY JOSEPH P (director) on 2024‑08‑15.
List of Insider Buy and Sell Transactions, CVRx, Inc.
| 2024-11-19 | Sale | CHIEF MKTG & STRAT OFFICER | 1,430 0.006% | $13.58 | $19,417 | +4.62% | ||
| 2024-08-15 | director | 3,000 0.0133% | $8.10 | $24,300 | 0.00% | |||
| 2024-08-08 | director | 3,000 0.0134% | $8.24 | $24,716 | +4.00% | |||
| 2024-08-06 | director | 2,500 0.0115% | $9.09 | $22,725 | -2.82% | |||
| 2024-08-05 | PRES & CEO | 30,000 0.1373% | $8.36 | $250,767 | +4.14% | |||
| 2024-02-20 | Sale | CHIEF MKTG & STRAT OFFICER | 2,545 0.0121% | $21.91 | $55,748 | -55.40% | ||
| 2024-02-16 | Sale | 10 percent owner | 3,725 0.0203% | $25.81 | $96,142 | -56.41% | ||
| 2023-08-03 | Sale | CHIEF MKTG & STRAT OFFICER | 628 0.0031% | $18.55 | $11,652 | -4.31% | ||
| 2023-07-31 | Sale | CHIEF MKTG & STRAT OFFICER | 1,122 0.0056% | $17.49 | $19,629 | -2.90% | ||
| 2022-11-28 | Sale | CHIEF MKTG & STRAT OFFICER | 4,600 0.023% | $11.94 | $54,931 | +27.16% | ||
| 2022-05-24 | 8,070 0.0378% | $5.05 | $40,752 | +81.37% | ||||
| 2022-05-19 | 10,976 0.0534% | $5.04 | $55,297 | +87.72% | ||||
| 2022-05-03 | 3,992 0.0194% | $6.00 | $23,936 | +54.82% | ||||
| 2022-04-28 | 41,988 0.1855% | $5.97 | $250,673 | +40.06% | ||||
| 2022-02-28 | director | 600 0.003% | $9.03 | $5,420 | -5.13% | |||
| 2022-02-24 | director | 3,400 0.0158% | $8.24 | $28,010 | -3.59% | |||
| 2022-02-23 | director | 38,200 0.1877% | $8.04 | $307,143 | +4.13% | |||
| 2022-02-22 | director | 40,008 0.1932% | $7.94 | $317,660 | +3.23% | |||
| 2022-02-18 | director | 26,659 0.1289% | $7.92 | $211,227 | +3.43% | |||
| 2021-11-19 | director | 600 0.006% | $13.69 | $8,213 | -38.88% |
Insider Historical Profitability
<0.0001%
| JOHNSON & JOHNSON | 10 percent owner | 4099575 16.8959% | $15.32 | 0 | 1 | |
| SLATTERY JOSEPH P | director | 30645 0.1263% | $15.32 | 3 | 0 | |
| Hykes Kevin | PRES & CEO | 30000 0.1236% | $15.32 | 1 | 0 | |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | 1875 0.0077% | $15.32 | 0 | 5 | |
| NEW ENTERPRISE ASSOCIATES 10 L P | 10 percent owner | 2026083 8.3503% | $15.32 | 1 | 0 | <0.0001% |
| NEA PARTNERS 10 L P | 10 percent owner | 2026083 8.3503% | $15.32 | 1 | 0 | <0.0001% |
| Pardo Geoffrey B | director | 1829022 7.5381% | $15.32 | 1 | 0 | <0.0001% |
| Nielsen Kirk G. | 1711355 7.0531% | $15.32 | 8 | 0 | +33.9% | |
| GLAXOSMITHKLINE PLC | 10 percent owner | 1007583 4.1526% | $15.32 | 1 | 0 | <0.0001% |
| NEHRA JOHN M | director | 28266 0.1165% | $15.32 | 3 | 0 | <0.0001% |
| Jain Mudit K. | director | 3400 0.014% | $15.32 | 6 | 0 | <0.0001% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Johnson & Johnson | $74.72M | 19 | 4.1M | +17.39% | +$11.07M | 1.75 | |
| Nea Management Company Llc | $43.17M | 10.98 | 2.37M | 0% | +$0 | 0.2 | |
| BlackRock | $13.93M | 3.54 | 764,999 | -4.78% | -$699,901.31 | <0.0001 | |
| Balyasny Asset Management Llc | $11.26M | 2.86 | 618,530 | +51.97% | +$3.85M | 0.03 | |
| The Vanguard Group | $10.82M | 2.75 | 594,312 | +5.64% | +$577,621.17 | <0.0001 | |
| Lord Abbett | $10.72M | 2.73 | 588,801 | -23.99% | -$3.38M | 0.04 | |
| Emerald Advisers, Inc. | $8.88M | 2.26 | 487,519 | +20.56% | +$1.51M | 0.36 | |
| EMERALD MUTUAL FUND ADVISERS TRUST | $7.01M | 1.78 | 385,034 | +17% | +$1.02M | 0.37 | |
| Parkman Healthcare Partners Llc | $6.05M | 1.54 | 332,090 | +38.37% | +$1.68M | 0.75 | |
| Archon Capital Management Llc | $5.18M | 1.32 | 284,408 | -0.39% | -$20,194.89 | 0.11 | |
| Geode Capital Management | $4.66M | 1.19 | 256,130 | +2.64% | +$119,962.71 | <0.0001 | |
| Silvercrest Asset Management Group Inc | $4.62M | 1.18 | 253,968 | +70.71% | +$1.92M | 0.03 | |
| State Street | $3.92M | 1 | 215,016 | +6.31% | +$232,341.37 | <0.0001 | |
| Morgan Stanley | $3.69M | 0.94 | 202,816 | +84.98% | +$1.7M | <0.0001 | |
| Point72 Asset Management | $3.55M | 0.9 | 195,218 | +943.95% | +$3.21M | 0.01 | |
| Schonfeld Group | $3.44M | 0.87 | 188,673 | +193.88% | +$2.27M | 0.02 | |
| ROYCE & ASSOCIATES INC | $2.08M | 0.53 | 114,000 | 0% | +$0 | 0.02 | |
| Citadel Advisors LLC | $1.86M | 0.47 | 102,291 | +935.44% | +$1.68M | <0.01 | |
| Mairs & Power, Inc. | $1.82M | 0.46 | 99,903 | +8.71% | +$145,680.03 | 0.02 | |
| Northern Trust | $1.7M | 0.43 | 93,554 | -1.73% | -$29,919.02 | <0.0001 | |
| Goldman Sachs | $1.4M | 0.36 | 76,690 | +270.43% | +$1.02M | <0.0001 | |
| Renaissance Technologies | $1.33M | 0.34 | 73,300 | +31.13% | +$316,903.14 | <0.01 | |
| Squarepoint Ops LLC | $1.33M | 0.34 | 72,834 | +237.48% | +$933,298.82 | 0.01 | |
| Two Sigma | $1.21M | 0.31 | 66,301 | +538.8% | +$1.02M | <0.01 | |
| Tudor Investment Corp Et Al | $1.07M | 0.27 | 58,802 | New | +$1.07M | 0.01 | |
| Soleus Capital Management, L.P. | $883,185.00 | 0.23 | 48,500 | New | +$883,185.00 | <0.01 | |
| Cubist Systematic Strategies | $838,580.00 | 0.21 | 46,051 | +476% | +$692,992.56 | 0.01 | |
| Nuveen | $770,083.00 | 0.2 | 42,289 | 0% | +$0 | <0.0001 | |
| RBF Capital, LLC | $721,863.00 | 0.18 | 39,641 | 0% | +$0 | 0.03 | |
| Cresset Asset Management Llc | $619,632.00 | 0.16 | 34,027 | 0% | +$0 | <0.01 | |
| Charles Schwab | $568,753.00 | 0.15 | 31,233 | 0% | +$0 | <0.0001 | |
| Jump Financial Llc | $561,742.00 | 0.14 | 30,848 | +94.22% | +$272,512.61 | 0.01 | |
| Walleye Capital | $562,379.00 | 0.14 | 30,883 | +115.54% | +$301,466.32 | <0.01 | |
| Bank of America | $536,722.00 | 0.14 | 29,474 | +2.15% | +$11,308.42 | <0.0001 | |
| JPMorgan Chase | $530,967.00 | 0.14 | 29,158 | +296.33% | +$396,996.08 | <0.0001 | |
| Level Four Advisory Services Llc | $908,144.00 | 0.13 | 28,885 | 0% | +$0 | 0.04 | |
| BNY Mellon | $518,074.00 | 0.13 | 28,450 | -24.5% | -$168,150.98 | <0.0001 | |
| Millennium Management LLC | $504,636.00 | 0.13 | 27,712 | -47.94% | -$464,646.80 | <0.0001 | |
| Two Sigma Advisers LP | $437,040.00 | 0.11 | 24,000 | New | +$437,040.00 | <0.01 | |
| Qube Research & Technologies | $421,343.00 | 0.11 | 23,138 | New | +$421,343.00 | <0.01 | |
| FourWorld Capital Management | $374,216.00 | 0.1 | 20,550 | New | +$374,216.00 | 0.54 | |
| Hrt Financial Llc | $367,000.00 | 0.09 | 20,193 | New | +$367,000.00 | <0.01 | |
| Kestra Advisory Services LLC | $350,998.00 | 0.09 | 19,275 | +33.62% | +$88,318.56 | <0.01 | |
| D. E. Shaw & Co. | $351,799.00 | 0.09 | 19,319 | -52.03% | -$381,572.35 | <0.0001 | |
| Valeo Financial Advisors LLC | $273,600.00 | 0.09 | 19,000 | New | +$273,600.00 | <0.01 | |
| Susquehanna International Group | $341,984.00 | 0.09 | 18,780 | -13.76% | -$54,575.40 | <0.0001 | |
| Jane Street Capital | $288,046.00 | 0.07 | 15,818 | -30.73% | -$127,761.46 | <0.0001 | |
| ExodusPoint Capital Management, LP | $263,000.00 | 0.07 | 14,463 | +42.62% | +$78,592.68 | <0.01 | |
| RhumbLine Advisers | $243,950.00 | 0.06 | 13,397 | +6.18% | +$14,203.25 | <0.0001 | |
| Centiva Capital | $217,100.00 | 0.06 | 11,922 | New | +$217,100.00 | 0.01 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.